4.3400.58% ( +0.025 )
Delay Closed: Nov 16, 16:08:11Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: GRANDPHARMA(00512) the Revenue is 3.194 B (+3.23%);the EBIT is 581.07 M (-5.79%);the EPS is 0.152 (-11.03%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
3.19B3.23%
----
----
EBIT
0.58B5.79%
----
----
EPS
0.151611.03%
----
----
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
